KNB.L

Kanabo Group Plc
Kanabo Group PLC - Result of AGM
27th June 2024, 15:49
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 2261U
Kanabo Group PLC
27 June 2024
 

27 June 2024

Kanabo Group Plc

("Kanabo" or the "Company")

 

Result of AGM

 

Kanabo Group Plc (LSE:KNB), a leading health tech company, announces that at the Annual General Meeting ("AGM") held earlier today, eight resolutions were duly passed. The numbers of votes for each resolution are presented below:

 

Resolution (No. as noted on proxy form)

Total For (i)

Total Against

Withheld (ii)

 

No. of votes

% of

vote

No. of votes

% of

vote

No. of votes

Resolution 1

 

226,464,519

99.86%

313,881

0.14%

129,393

Resolution 2

 

218,146,960

96.31%

8,339,516

3.68%

420,817

Resolution 3

 

226,331,517

99.83%

376,111

0.17%

200,165

Resolution 4

 

218,268,057

96.28%

8,436,008

3.72%

203,728

Resolution 5

 

216,203,853

95.36%

10,500,212

4.63%

203,728

Resolution 6

 

216,246,519

95.38%

10,457,546

4.61%

203,728

Resolution 7

 

226,256,746

99.80%

447,319

0.20%

203,728

Resolution 8

 

155,841,995

68.79%

70,696,796

31.21%

368,502

Resolution 9 (iii)

 

155,793,930

68.78%

70,707,021

31.%

406,342

 

(i)            The "For" Proxy vote includes those giving the Chair of the AGM discretion

(ii)           A vote "Withheld" is not a vote in law and is not included in the proxy votes "For" or "Against" the resolution

(iii)          Special resolution

 

The full text of the resolutions can be found in the Notice of Annual General Meeting, which is available on the Company's website at: https://www.kanabogroup.com/investors/

 

 For further information, please visit http://www.kanabogroup.com/ or contact the following:

 

Enquiries:

 

Kanabo Group plc

Avihu Tamir, Chief Executive Officer

Assaf Vardimon, Chief Financial Officer
Ian Mattioli, Non-Executive Chair of the Board

 

via Peterhouse Capital

+44 (0)20 7469 0930

 


Peterhouse Capital Limited  (Financial Adviser and Broker)

+44 (0)20 7469 0930

 

                                                                               

 

About Kanabo Group Plc

 

Kanabo Group Plc (LSE:KNB) is a healthtech company committed to revolutionising patient care through its innovative technology platform and disruptive product offerings. Since its inception in 2017, Kanabo has been focused on researching, developing, and commercialising regulated medicinal cannabis-derived formulations and therapeutic inhalation devices.

 

Kanabo's NHS-approved online telehealth platform, The GP Service, provides patients with video consultations, online prescriptions, and primary care services. The Company is a leader in its field, focusing on improving patient outcomes and providing more accessible healthcare experiences.

 

In March 2023, Kanabo successfully launched its Pain Clinic, Treat It, under the expert guidance of its technological and product expertise. Treat It initially focuses on chronic pain management using plant-based medicine and treatments that are currently unavailable through traditional channels.

 

At Kanabo Group Plc, we are dedicated to providing patients with the highest quality medical treatments and more accessible healthcare experiences.

 

Visit www.kanabogroup.com for more information.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGEASKXALKLEFA]]>
TwitterFacebookLinkedIn